Gelao, L.; Criscitiello, C.; Esposito, A.; Goldhirsch, A.; Curigliano, G.
Immune Checkpoint Blockade in Cancer Treatment: A Double-Edged Sword Cross-Targeting the Host as an “Innocent Bystander”. Toxins 2014, 6, 914-933.
https://doi.org/10.3390/toxins6030914
AMA Style
Gelao L, Criscitiello C, Esposito A, Goldhirsch A, Curigliano G.
Immune Checkpoint Blockade in Cancer Treatment: A Double-Edged Sword Cross-Targeting the Host as an “Innocent Bystander”. Toxins. 2014; 6(3):914-933.
https://doi.org/10.3390/toxins6030914
Chicago/Turabian Style
Gelao, Lucia, Carmen Criscitiello, Angela Esposito, Aron Goldhirsch, and Giuseppe Curigliano.
2014. "Immune Checkpoint Blockade in Cancer Treatment: A Double-Edged Sword Cross-Targeting the Host as an “Innocent Bystander”" Toxins 6, no. 3: 914-933.
https://doi.org/10.3390/toxins6030914
APA Style
Gelao, L., Criscitiello, C., Esposito, A., Goldhirsch, A., & Curigliano, G.
(2014). Immune Checkpoint Blockade in Cancer Treatment: A Double-Edged Sword Cross-Targeting the Host as an “Innocent Bystander”. Toxins, 6(3), 914-933.
https://doi.org/10.3390/toxins6030914